Brief: Biorestorative Announces Positive Outcome From Type B Meeting With FDA
11/02/2026 12:46
Feb 11 (Reuters) - BioRestorative Therapies Inc BRTX.O: BIORESTORATIVE ANNOUNCES POSITIVE OUTCOME FROM TYPE B MEETING WITH FDA BIORESTORATIVE THERAPIES INC: CURRENTLY ANTICIPATES THAT PHASE 3 TRIAL IND SUBMISSION WILL BE MADE IN SECOND HALF OF 2026 Source text: ID:nGNX8tTDsc Further company coverage: BRTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM